News
Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.
Giant cell arteritis (GCA), also known as temporal arteritis, is an autoimmune disease of medium and large arteries, characterized by granulomatous inflammation of the three-layered vessel wall, which ...
The Food and Drug Administration (FDA) has approved Rinvoq ® (upadacitinib), a Janus kinase (JAK) inhibitor, for the treatment of adults with giant cell arteritis (GCA). The approval was based on data ...
Patients with newly diagnosed giant cell arteritis (GCA) experience significant delays in accessing subcutaneous tocilizumab (TCZ), with an average wait of 43 days from medication request to ...
The best cheap cell phone plans offer reliable coverage, fast speeds, and enough data for your needs at affordable prices. Budget phone plans typically come from carriers known as mobile virtual ...
And if you do, then you've no doubt come across Meta AI. The tech giant has woven artificial intelligence into how you interact on these apps, including helping with posts and editing images.
Giant cell arteritis (GCA), also known as temporal arteritis, is an autoimmune disease of medium and large arteries, characterized by granulomatous inflammation of the three-layered vessel wall, which ...
Various bread products sold at Giant Eagle stores in Ohio and Pennsylvania have been recalled after glass was found on top of the bread. According to the U.S. Food and Drug Administration (FDA ...
17d
Pharmaceutical Technology on MSNFDA approves AbbVie’s upadacitinib for giant cell arteritisThe US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA). The approval follows the recent marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results